Zeo ScientifiX, Inc.
ZEOX
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.29M
Close$
Share Statistics
| Market cap | $9.29 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.86 |
| Beta | 1.74 |
| Outstanding Shares | 7,757,469 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -2.04 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$1.70 M
Average shareholder expectationNext Earnings Call
Expected Date
December 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$1.70 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zeo ScientifiX, Inc.
20 employees
CEO: Ian T. Bothwell Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company specializing in developing biological therapeutics aimed at treating degenerative diseases and fostering regenerative medicine. Its flagship investigational product, Zofi...